Literature DB >> 21190101

Prognostic relevance of pathologic subtypes and minimal invasion in intraductal papillary mucinous neoplasms of the pancreas.

Jeong Kim1, Kee-Taek Jang, Sang Mo Park, Seong Woo Lim, Jung Ha Kim, Kwang Hyuck Lee, Jong Kyun Lee, Jin Seok Heo, Seong-Ho Choi, Dong Wook Choi, Jong Chul Rhee, Kyu Taek Lee.   

Abstract

Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are classified into the following four histopathologic subtypes: gastric, intestinal, pancreatobiliary, and oncocytic. However, the clinicopathologic characteristics of IPMN subtypes have not been fully clarified. Recently, a subgroup classification of minimally invasive intraductal papillary mucinous carcinomas (MI-IPMCs) was suggested in contrast to overt invasive carcinoma from IPMCs (IC-IPMCs). The purpose of this study was to determine whether or not the pathologic subtype classification can predict prognosis and to validate the usefulness of the newly proposed diagnostic criteria of MI-IPMCs. We reviewed the clinicopathologic characteristics of 142 surgically resected cases of IPMNs. There were 54, 56, 30, and two cases of the gastric, intestinal, pancreatobiliary, and oncocytic types of IPMNs, respectively. The intestinal and pancreatobiliary types were more likely to have a main duct type. All gastric type tumors were adenomas or moderate dysplasia, whereas greater than one half of the intestinal and pancreatobiliary types were carcinomas in situ or invasive carcinomas. A significant difference in recurrence and death rate was noted for invasive carcinoma between the intestinal and pancreatobiliary types. The majority of MI-IPMCs were the intestinal type, whereas the majority of IC-IPMCs were the pancreatobiliary type. The IC-IPMC group showed a decreased recurrence-free and overall survival with statistically significance (p < 0.001 and p = 0.001, respectively). Our results suggest that the pathologic subtype classification and the newly proposed diagnostic criteria for minimal invasion may also be useful to predict prognosis of IPMNs of the pancreas.

Entities:  

Mesh:

Year:  2010        PMID: 21190101     DOI: 10.1007/s13277-010-0148-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  14 in total

Review 1.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

2.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.

Authors:  Toru Furukawa; Günter Klöppel; N Volkan Adsay; Jorge Albores-Saavedra; Noriyoshi Fukushima; Akira Horii; Ralph H Hruban; Yo Kato; David S Klimstra; Daniel S Longnecker; Jutta Lüttges; G Johan A Offerhaus; Michio Shimizu; Makoto Sunamura; Arief Suriawinata; Kyoichi Takaori; Suguru Yonezawa
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

4.  Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Keita Wada; Richard A Kozarek; L William Traverso
Journal:  Am J Surg       Date:  2005-05       Impact factor: 2.565

5.  Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

Authors:  Nobuyoshi Hiraoka; Kaoru Onozato; Tomoo Kosuge; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

6.  Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.

Authors:  Shinichi Ban; Yoshihisa Naitoh; Mari Mino-Kenudson; Takaki Sakurai; Makoto Kuroda; Isamu Koyama; Gregory Y Lauwers; Michio Shimizu
Journal:  Am J Surg Pathol       Date:  2006-12       Impact factor: 6.394

7.  Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.

Authors:  Naoki Takasu; Wataru Kimura; Toshiyuki Moriya; Ichiro Hirai; Akiko Takeshita; Yukinori Kamio; Takashi Nomura
Journal:  Pancreas       Date:  2010-07       Impact factor: 3.327

Review 8.  An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Authors:  Ralph H Hruban; Kyoichi Takaori; David S Klimstra; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Sandra A Biankin; Carolyn Compton; Noriyoshi Fukushima; Toru Furukawa; Michael Goggins; Yo Kato; Gunter Klöppel; Daniel S Longnecker; Jutta Lüttges; Anirban Maitra; G Johan A Offerhaus; Michio Shimizu; Suguru Yonezawa
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

9.  Branch duct intraductal papillary mucinous neoplasms in a retrospective series of 190 patients.

Authors:  S M Woo; J K Ryu; S H Lee; W J Yoon; Y-T Kim; Y B Yoon
Journal:  Br J Surg       Date:  2009-04       Impact factor: 6.939

10.  Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.

Authors:  Satoshi Nara; Kazuaki Shimada; Tomoo Kosuge; Yae Kanai; Nobuyoshi Hiraoka
Journal:  Am J Surg Pathol       Date:  2008-02       Impact factor: 6.394

View more
  14 in total

1.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

2.  The Clinical Indications for Limited Surgery of Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Kenjiro Kimura; Ryosuke Amano; Sadaaki Ymazoe; Go Ohira; Kohei Nishio; Kosei Hirakawa; Masaichi Ohira
Journal:  World J Surg       Date:  2017-05       Impact factor: 3.352

Review 3.  Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Víctor M Castellano-Megías; Carolina Ibarrola-de Andrés; Guadalupe López-Alonso; Francisco Colina-Ruizdelgado
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

4.  Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis.

Authors:  Jordan M Winter; Wei Jiang; Olca Basturk; Mari Mino-Kenudson; Zhi Ven Fong; Wei Phin Tan; Harish Lavu; Charles M Vollmer; Emma E Furth; Dana Haviland; David S Klimstra; William R Jarnagin; Keith D Lillemoe; Charles J Yeo; Carlos Fernandez-Del Castillo; Peter J Allen
Journal:  Ann Surg       Date:  2016-04       Impact factor: 12.969

5.  Interobserver variability in intraductal papillary mucinous neoplasm subtypes and application of their mucin immunoprofiles.

Authors:  Heewon A Kwak; Xiuli Liu; Daniela S Allende; Rish K Pai; John Hart; Shu-Yuan Xiao
Journal:  Mod Pathol       Date:  2016-05-20       Impact factor: 7.842

6.  Endoscopic ultrasound-guided fine needle aspiration in cystic pancreatic lesions.

Authors:  Robert H Hawes; James Clancy; Muhammad K Hasan
Journal:  Clin Endosc       Date:  2012-06-30

7.  IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection.

Authors:  Giovanni Marchegiani; Mari Mino-Kenudson; Klaus Sahora; Vicente Morales-Oyarvide; Sarah Thayer; Cristina Ferrone; Andrew L Warshaw; Keith D Lillemoe; Carlos Fernández-Del Castillo
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

Review 8.  Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.

Authors:  M Distler; D Aust; J Weitz; C Pilarsky; Robert Grützmann
Journal:  Biomed Res Int       Date:  2014-03-24       Impact factor: 3.411

9.  Intraductal papillary mucinous neoplasms of the pancreas: Clinical association with KRAS.

Authors:  Xiao Yan Chang; Yan Wu; Yuan Li; Jing Wang; Jie Chen
Journal:  Mol Med Rep       Date:  2018-04-12       Impact factor: 2.952

10.  Microinvasion of high-grade pancreatic intraepithelial neoplasia.

Authors:  Natsuko Kawada; Hiroyuki Uehara; Ryoji Takada; Takuo Yamai; Nobuyasu Fukutake; Kazuhiro Katayama; Akemi Takenaka; Shigenori Nagata; Yasuhiko Tomita
Journal:  Case Rep Gastroenterol       Date:  2013-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.